Concord Medical Services stock analysis
Want to see CCM full AI Analyst Report?
Concord Medical Services (CCM) Stock Price & Analysis
CCM Stock Chart & Stats
- Day’s Range
- $3.44 - $3.77
- 52-Week Range
- $2.79 - $6.80
- Previous Close
- $3.62
- Volume
- N/A
- Average Volume (3M)
- 16.01K
- Market Cap
- $15.59M
- Enterprise Value
- $3342.59T
- Total Cash (Recent Filing)
- $297.79M
- Total Debt (Recent Filing)
- $3.63B
- Price to Earnings (P/E)
- ―
- Beta
- 1.04
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Dec 23, 2015
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The strong 2025 revenue rebound indicates renewed demand for CCM’s oncology-related services and improved business activity after the prior-year decline. If maintained, higher patient volumes and equipment utilization could provide a foundation for operating improvement across the company’s specialized care network.
Smaller Net Loss
The substantial reduction in net loss shows that financial performance improved meaningfully from the prior year, even though CCM remains unprofitable. Continued progress would reduce the earnings drag on the business and could strengthen its ability to stabilize operations over the next several reporting periods.
Management Continuity
The appointment of an interim CFO with longstanding board and asset-management experience within the group supports continuity during a senior finance transition. Maintaining experienced oversight of oncology operations and financial processes can help preserve execution stability while the company addresses its broader financial challenges.
Bears Say
Highly Stressed Balance Sheet
Very high debt combined with deeply negative equity materially restricts CCM’s financial flexibility. This capital structure leaves less capacity to fund oncology-center investment internally, absorb operating setbacks, or manage obligations without relying on refinancing, asset actions, or other external financial support.
Persistent Cash Burn
Negative operating and free cash flow indicate that the core business is still not self-funding despite improvement from 2024. Continued cash consumption can increase dependence on external financing and constrain spending on equipment, clinical capacity, and other investments needed to support durable growth.
Unprofitable Cost Structure
A multi-year pattern of operating and net losses, together with volatile gross profit, suggests that revenue growth has not yet translated into a sustainable earnings model. Weak or inconsistent gross economics may limit reinvestment capacity and leave profitability vulnerable if utilization or reimbursement conditions weaken.
CCM FAQ
What was Concord Medical Services’s price range in the past 12 months?
What is Concord Medical Services’s market cap?
When is Concord Medical Services’s upcoming earnings report date?
How were Concord Medical Services’s earnings last quarter?
Is Concord Medical Services overvalued?
Does Concord Medical Services pay dividends?
What is Concord Medical Services’s EPS estimate?
How many shares outstanding does Concord Medical Services have?
What happened to Concord Medical Services’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Concord Medical Services?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Jianyu Yang
- Employees
- 610
- Website
- www.concordmedical.com
- Address
- East Zone, Hanwei Plaza, Beijing, NY, 100020, CN
Concord Medical Services (CCM) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 6 | 12 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 1 | 0 | 11 |









